News Conference News VIVA 2023 PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI L.A. McKeown November 01, 2023
News Conference News ACC 2020 Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients L.A. McKeown April 01, 2020